Literature DB >> 25434725

Inhibition of HDAC6 modifies tau inclusion body formation and impairs autophagic clearance.

Janina Leyk1, Olaf Goldbaum, Monika Noack, Christiane Richter-Landsberg.   

Abstract

Proteinaceous inclusions in nerve cells and glia are a defining neuropathological hallmark in a variety of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD). Their occurrence may be related to malfunctions of the proteolytic degradation systems. In cultured oligodendrocytes, proteasomal inhibition leads to protein aggregate formation resembling coiled bodies, which are characteristic for PSP and CBD. Large protein aggregates are excluded from the proteasome and can only be degraded by autophagy, a lysosomal pathway. Autophagy is a highly selective process, which requires a variety of receptor proteins for ubiquitinated proteins, such as p62 and histone deacetylase 6 (HDAC6). HDAC6 is mainly localized in the cytoplasm, and alpha-tubulin is its major substrate. HDAC6 is considered as a sensor of proteasomal stress; it is involved in the autophagosomal pathway and can mediate the retrograde transport of ubiquitinated proteins along the microtubules. As we have shown recently, HDAC6 is present in oligodendrocytes and its inhibition leads to morphological alterations, microtubule bundling, modulation of acetylation, and phosphorylation of the microtubule-associated protein tau. The present study was undertaken to investigate whether HDAC6 is involved in protein aggregate formation in oligodendrocytes and whether its inhibition modifies the consequences of MG-132-induced inhibition of the ubiquitin proteasome system (UPS). The data show that HDAC6 and acetylated tau are recruited to protein aggregates after proteasomal inhibition. Pharmacological inhibition of HDAC6 by the selective inhibitor tubastatin A (TST) and its small hairpin RNA (shRNA)-mediated downregulation alters the assembly of MG-132-induced compact protein aggregates. After TST treatment, they appear more diffusely dispersed throughout the cytoplasm. This is not a protective means but promotes the onset of apoptotic cell death. Furthermore, the heat shock response is altered, and TST suppresses the MG-132-stimulated induction of HSP70. To test whether the alteration of protein aggregate formation is related to the influence of HDAC6 on the autophagic degradation system, an oligodendroglial cell line, i.e., OLN-93 cells stably expressing green fluorescent protein (GFP)-microtubule associated protein light chain 3 (LC3) and tau, was used. During autophagosome formation, endogenous LC3 is processed to LC3-I, which is then converted to LC3-II. An increase of LC3-II is used as a reliable marker for autophagosome formation and abundance. It is demonstrated that inhibition of HDAC6 leads to the accumulation of LC3-positive autophagosomal vacuoles and an increase in LC3-II immunoreactivity, but the autophagic flux is rather impaired. Hence, the inhibition or dysregulation of HDAC6 contributes to stress responses and pathological processes in oligodendrocytes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25434725     DOI: 10.1007/s12031-014-0460-y

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  55 in total

Review 1.  Tau-inclusion body formation in oligodendroglia: the role of stress proteins and proteasome inhibition.

Authors:  Christiane Richter-Landsberg; Nina G Bauer
Journal:  Int J Dev Neurosci       Date:  2004-11       Impact factor: 2.457

2.  Regulation of microtubule dynamics by inhibition of the tubulin deacetylase HDAC6.

Authors:  Yuliya Zilberman; Christoph Ballestrem; Letizia Carramusa; Ralph Mazitschek; Saadi Khochbin; Alexander Bershadsky
Journal:  J Cell Sci       Date:  2009-09-08       Impact factor: 5.285

3.  HDAC6-p97/VCP controlled polyubiquitin chain turnover.

Authors:  Cyril Boyault; Benoit Gilquin; Yu Zhang; Vladimir Rybin; Elspeth Garman; Wolfram Meyer-Klaucke; Patrick Matthias; Christoph W Müller; Saadi Khochbin
Journal:  EMBO J       Date:  2006-06-29       Impact factor: 11.598

Review 4.  The emerging role of acetylation in the regulation of autophagy.

Authors:  Agnes Bánréti; Miklós Sass; Yacine Graba
Journal:  Autophagy       Date:  2013-03-06       Impact factor: 16.016

5.  Inhibition of protein deubiquitination by PR-619 activates the autophagic pathway in OLN-t40 oligodendroglial cells.

Authors:  Veronika Seiberlich; Janika Borchert; Victoria Zhukareva; Christiane Richter-Landsberg
Journal:  Cell Biochem Biophys       Date:  2013-09       Impact factor: 2.194

Review 6.  Autophagy in neurodegenerative disease: friend, foe or turncoat?

Authors:  Ralph A Nixon
Journal:  Trends Neurosci       Date:  2006-07-20       Impact factor: 13.837

7.  Proteasome inhibition by MG-132 induces apoptotic cell death and mitochondrial dysfunction in cultured rat brain oligodendrocytes but not in astrocytes.

Authors:  Olaf Goldbaum; Grit Vollmer; Christiane Richter-Landsberg
Journal:  Glia       Date:  2006-06       Impact factor: 7.452

Review 8.  Regulation mechanisms and signaling pathways of autophagy.

Authors:  Congcong He; Daniel J Klionsky
Journal:  Annu Rev Genet       Date:  2009       Impact factor: 16.830

9.  HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy.

Authors:  Joo-Yong Lee; Hiroshi Koga; Yoshiharu Kawaguchi; Waixing Tang; Esther Wong; Ya-Sheng Gao; Udai B Pandey; Susmita Kaushik; Emily Tresse; Jianrong Lu; J Paul Taylor; Ana Maria Cuervo; Tso-Pang Yao
Journal:  EMBO J       Date:  2010-01-14       Impact factor: 11.598

Review 10.  HDAC6, at the crossroads between cytoskeleton and cell signaling by acetylation and ubiquitination.

Authors:  C Boyault; K Sadoul; M Pabion; S Khochbin
Journal:  Oncogene       Date:  2007-08-13       Impact factor: 9.867

View more
  21 in total

Review 1.  Sorting out release, uptake and processing of alpha-synuclein during prion-like spread of pathology.

Authors:  Trevor Tyson; Jennifer A Steiner; Patrik Brundin
Journal:  J Neurochem       Date:  2016-02-10       Impact factor: 5.372

Review 2.  Therapeutic Strategies for Restoring Tau Homeostasis.

Authors:  Zapporah T Young; Sue Ann Mok; Jason E Gestwicki
Journal:  Cold Spring Harb Perspect Med       Date:  2018-01-02       Impact factor: 6.915

Review 3.  The fine-tuning of proteolytic pathways in Alzheimer's disease.

Authors:  Valentina Cecarini; Laura Bonfili; Massimiliano Cuccioloni; Matteo Mozzicafreddo; Mauro Angeletti; Jeffrey N Keller; Anna Maria Eleuteri
Journal:  Cell Mol Life Sci       Date:  2016-04-27       Impact factor: 9.261

4.  UCH-L1 Inhibition Suppresses tau Aggresome Formation during Proteasomal Impairment.

Authors:  Quntao Yu; Hongmao Zhang; Yuan Li; Chao Liu; Shaohui Wang; Xiaomei Liao
Journal:  Mol Neurobiol       Date:  2017-05-24       Impact factor: 5.590

5.  Inhibition of HDAC6 protects against rhabdomyolysis-induced acute kidney injury.

Authors:  Yingfeng Shi; Liuqing Xu; Jinhua Tang; Lu Fang; Shuchen Ma; Xiaoyan Ma; Jing Nie; Xiaoling Pi; Andong Qiu; Shougang Zhuang; Na Liu
Journal:  Am J Physiol Renal Physiol       Date:  2017-01-04

6.  Nitrosylation of GAPDH augments pathological tau acetylation upon exposure to amyloid-β.

Authors:  Tanusree Sen; Pampa Saha; Nilkantha Sen
Journal:  Sci Signal       Date:  2018-03-20       Impact factor: 8.192

Review 7.  Monoaminergic neuropathology in Alzheimer's disease.

Authors:  Goran Šimić; Mirjana Babić Leko; Selina Wray; Charles R Harrington; Ivana Delalle; Nataša Jovanov-Milošević; Danira Bažadona; Luc Buée; Rohan de Silva; Giuseppe Di Giovanni; Claude M Wischik; Patrick R Hof
Journal:  Prog Neurobiol       Date:  2016-04-12       Impact factor: 11.685

Review 8.  The Interplay between Alpha-Synuclein Clearance and Spreading.

Authors:  Tomás Lopes da Fonseca; Anna Villar-Piqué; Tiago Fleming Outeiro
Journal:  Biomolecules       Date:  2015-04-14

Review 9.  Tau Protein Hyperphosphorylation and Aggregation in Alzheimer's Disease and Other Tauopathies, and Possible Neuroprotective Strategies.

Authors:  Goran Šimić; Mirjana Babić Leko; Selina Wray; Charles Harrington; Ivana Delalle; Nataša Jovanov-Milošević; Danira Bažadona; Luc Buée; Rohan de Silva; Giuseppe Di Giovanni; Claude Wischik; Patrick R Hof
Journal:  Biomolecules       Date:  2016-01-06

10.  The Autotaxin-Lysophosphatidic Acid Axis Modulates Histone Acetylation and Gene Expression during Oligodendrocyte Differentiation.

Authors:  Natalie A Wheeler; James A Lister; Babette Fuss
Journal:  J Neurosci       Date:  2015-08-12       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.